Tamoxifen combined with sumer extract in the treatment of endometriosis in rats

endometriosis;ezrin;sumeria;tamoxifen;vascular endothelial growth factor

Supporting Agencies Copyright (c) 2020 Z. Y. Fang, H. Y. Yang, Y. Q. Ma, W. Wei, W. Y. Wu This site is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Editor-in-Chief Medical Genetics, University of Torino Medical School, Italy Co-Editor-in-Chief Department of Biomedical, Surgical and Dental Sciences, University of Milan, Italy Indexing & Archiving News & Announcements 2026-02-09 Journal of Biological Regulators and Homeostatic Agents (JBRHA, Print ISSN: 0393-974X, Electronic ISSN: 1724-6083) has officially transitioned to China Scientific Research Publishing, taking over publication from Asia Pacific Academy of Science Pte. Ltd. with effect from Vol 40, No 1 (2026). All new submissions should be made via the new journal website at https://journal.csrp-pub.com/index.php/jbrha from February 10, 2026. For any inquiries regarding this transition and the publication of manuscripts being processed, please contact the new publisher at [email protected] or [email protected]. 2025-02-01 In addition to the first issue that has already been published by the original publisher, there will be four more issues released this year, with scheduled publication dates in March, June, September, and December respectively. 2025-01-21 Starting from Volume 39 Issue 2 (2025), the ownership of Journal of Biological Regulators and Homeostatic Agents (ISSN: 0393-974X (P); 1724-6083 (O)) will be transferred from Biolife Sas to Asia Pacific Academy of Science Pte. Ltd. As of 21 January 2025, authors should make submissions to the new journal system and follow the author guidelines. Asia Pacific Academy of Science Pte. Ltd. will take over the publication of manuscripts being processed.